Elutia Inc. rose 11.6% on Tuesday, November 10, 2026, on 298,100 shares. No headline about ELUT came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Elutia Inc. (ELUT:NASDAQ) closed at $0.820 on November 13, 2026, down 6.69% on the day. The stock trades 40.8% below its 52-week high of $1.39 and 64.0% above its 52-week low of $0.500. Over the past year, it gained 12.3%. Elutia Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ELUT closed higher on 106 days (42%). Its best day was January 13, 2026 (+27.14%) and its worst was December 16, 2025 (-18.66%). The stock moved 10% or more in a single session 7 times.
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Find more stocks like ELUT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.